# US 5,858,756 A · Human lysophospholipase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,858,756 A
- Document ID: US5858756A
- Status: Granted
- Kind: A
- Application number: 08/844,120
- Filed: 1997-04-29
- Granted: 1999-01-12
- Earliest claimed: 1997-04-29
- Assignees: Incyte Pharmaceuticals, Inc.
- Inventors: Jennifer L. Hillman; Purvi Shah; Lynn E. Murry
- Web page: https://patentgrep.com/patent/US5858756A

## CPC

- C12N 9/18: Carboxylic ester hydrolases {(3.1.1)}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a human lysophospholipase (NHLP) and polynucleotides which identify and encode NHLP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. In addition, the invention provides methods for producing NHLP and for treating or preventing disorders associated with expression of NHLP.

## Claims

### Claim 1

An isolated and purified polynucleotide comprising the coding region of SEQ ID No:2.

### Claim 2 (depends on 1)

A composition comprising the polynucleotide of claim 1.

### Claim 3

An isolated and purified polynucleotide comprising SEQ ID NO:2.

### Claim 4 (depends on 1)

An isolated and purified polynucleotide which is completely complementary to the polynucleotide of claim 1.

### Claim 5 (depends on 4)

A composition comprising the isolated and purified polynucleotide of claim 4.

### Claim 6 (depends on 1)

An expression vector comprising the polynucleotide of claim 1.

### Claim 7 (depends on 6)

A host cell comprising the expression vector of claim 6.

### Claim 8 (depends on 7)

A method for producing a polypeptide comprising the amino acid sequence of SEQ ID NO:1, the method comprising the steps of:
a) culturing the host cell of claim 7 under conditions suitable for the expression of the polypeptide; and p1 b) recovering the polypeptide from the host cell culture.
